VivoSeq
Other

Anosmia

11

Pipeline Programs↗

2

Active Trials↗

6

Companies Involved↗

Anosmia is an emerging landscape with 11 programs across 6 companies. The most active players are Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Salix, Arbor Pharmaceuticals, Inc.. 6 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

38/100

Pipeline Velocity

6/100

Mech. Concentration

50/100

Completion Rate

60/100

Attrition Rate

29/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

P

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

1 program

Phase 1S

Salix

1 program

Phase 2A

Arbor Pharmaceuticals, Inc.

1 program

ApprovedE

Ever Neuro Pharma GmbH

1 program

ApprovedC

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

1 program

ApprovedPfizer logo

Pfizer

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

14

clinical trials

Completed6 · 43%
Withdrawn3 · 21%
Not yet recruiting2 · 14%
Unknown status2 · 14%
Terminated1 · 7%

Clinical Trials

Trial Activity

14 trials

Intranasal Platelet-Rich Plasma With or Without Topical Insulin for Post-Inflammatory Anosmia
Not yet recruiting·—·N/A·NCT07383415·20 enrolled
Efficacy of Platelet-rich Plasma in Management of Anosmia
Not yet recruiting·SSohag University·N/A·NCT06930248·100 enrolled
The Effect of Oral Theophylline on Traumatic Anosmia
Completed·TTaichung Veterans General Hospital·Phase 4·NCT07171021·158 enrolled
The Effect of Chinese Herbal Medicine as an Adjuvant Therapy in the Treatment of Traumatic Anosmia
Completed·TTaichung Veterans General Hospital·N/A·NCT05199623·77 enrolled
Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia
Completed·—·Phase 3·NCT04830943·250 enrolled
NAC Trial for Anosmia
Completed·UUniversity of Miami·Phase 1·NCT02481609·29 enrolled
Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants
Completed·—·Phase 4·NCT06208540·160 enrolled
Preparation and Characterization Intranasal Film Loaded With Steroid as a Local Treatment of Anosmia in Compare to Insulin Intranasal Film
Completed·—·Phase 1/2·NCT05328414·200 enrolled
NAC for Head Trauma-induced Anosmia
Terminated·UUniversity of Miami·Phase 3·NCT03680911·7 enrolled
Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia
Withdrawn·UUniversity of Nebraska·Phase 1·NCT06498687
Coronavirus Smell Therapy for Anosmia Recovery
Withdrawn·WWashington University School of Medicine·Phase 2·NCT04422275
Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)
Withdrawn·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 4·NCT04374474
Anosmia and / or Ageusia and Early Corticosteroid Use
Unknown status·CClinAmygate·Phase 4·NCT04528329·300 enrolled
Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia
Unknown status·SSouth Valley University·Phase 2/3·NCT04951362·117 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)